In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of the Company, Advik Laboratories Limited, at their meeting held today i.e., Friday, April 15, 2022, at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi 110001 at 03:00 P.M. has, inter alia, considered and approved the following business: I. Increase and alteration of the Authorized Share Capital of the Company from Rs. 20,00,00,000/- (Rupees Twenty Crores only) divided into 2,00,00,000 (Two Crore) Equity Shares of Rs. 10/- each to Rs. 45,00,00,000/- (Rupees Forty-Five Crores only) divided into 4,50,00,000 (Four Crore Fifty Lakh) Equity Shares of Rs. 10/- each.